SHTPY · SCHOTT Pharma AG & Co. KGaA · Analyst Estimates
$6.55
At close · Sep 14
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$3.95B
Shares
602.46M
Volume · Sep 14
469
Avg daily vol (2 sessions)
469
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for SCHOTT Pharma AG & Co. KGaA across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Published by the company
Source collection is delayed; the retained verified snapshot may not include newer publications.
A newer capture has not passed verification. Showing the last verified snapshot.
Captured 2026-10-11 08:58 UTC · Publication dates shown per estimate · 54 metric / period groups
FY 2026 E
| Metric | Low | Average | High | Consensus (Mean) | Highest | Lowest | Median | Number of Estimates |
|---|---|---|---|---|---|---|---|---|
|
Capex
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
Capex
[EUR m]
2026-10-09 |
— | — | — |
-151.7
|
-131.7
|
-167.0
|
-153.1
|
— |
|
DCS, EBITDA
2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DCS, EBITDA
[EUR m]
2026-10-09 |
— | — | — | — |
146.0
|
— | — | — |
|
DCS, EBITDA
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
139.2
|
— |
132.6
|
139.5
|
— |
|
DCS, EBITDA Margin (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DCS, EBITDA Margin (in %)
(in %)
Consensus as of: 2026-10-09 |
— | — | — |
24.0
|
25.3
|
23.3
|
24.0
|
— |
|
DCS, Revenue
2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DCS, Revenue
[EUR m]
2026-10-09 |
— | — | — |
579.3
|
583.0
|
569.9
|
580.5
|
— |
|
DDS, EBITDA
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DDS, EBITDA
EUR m
Consensus as of: 2026-10-09 |
— | — | — |
145.7
|
150.7
|
141.6
|
144.0
|
— |
|
DDS, EBITDA Margin (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DDS, EBITDA Margin (in %)
in %
Consensus as of: 2026-10-09 |
— | — | — |
32.1
|
34.0
|
30.5
|
31.9
|
— |
|
DDS, Revenue
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DDS, Revenue
EUR m
Consensus as of: 2026-10-09 |
— | — | — | — | — |
435.0
|
— | — |
|
DDS, Revenue
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
454.4
|
472.0
|
— |
456.9
|
— |
|
DPS
2026-10-09 |
— | — | — |
0.18
|
0.21
|
0.14
|
0.18
|
14
|
|
EBIT
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
EBIT
[EUR m]
2026-10-09 |
— | — | — |
195.6
|
205.0
|
189.3
|
196.0
|
— |
|
EBITDA
[EUR m]
2026-10-09 |
— | — | — |
283.9
|
— |
276.2
|
284.6
|
— |
|
EBITDA
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
EBITDA
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — | — |
290.0
|
— | — | — |
|
EBITDA Margin
2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
EBITDA Margin
(in %)
2026-10-09 |
— | — | — |
27.4
|
27.6
|
27.1
|
27.4
|
— |
|
EPS
2026-10-09 |
— | — | — |
0.97
|
1.06
|
0.93
|
0.97
|
14
|
|
FCF
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
FCF
[EUR m]
2026-10-09 |
— | — | — |
63.9
|
152.9
|
11.0
|
65.7
|
— |
|
Net income
2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
Net income
[EUR m]
2026-10-09 |
— | — | — |
147.0
|
160.0
|
140.0
|
146.5
|
— |
|
Organic revenue growth (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
10
|
|
Organic revenue growth (in %)
(in %)
Consensus as of: 2026-10-09 |
— | — | — |
5.1
|
6.3
|
2.8
|
5.5
|
— |
|
Revenue
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
Revenue
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
1,035.7
|
1,051.2
|
1,012.5
|
1,040.7
|
— |
FY 2027 E
| Metric | Low | Average | High | Consensus (Mean) | Highest | Lowest | Median | Number of Estimates |
|---|---|---|---|---|---|---|---|---|
|
Capex
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
Capex
[EUR m]
2026-10-09 |
— | — | — |
-153.4
|
-129.3
|
-174.0
|
-153.0
|
— |
|
DCS, EBITDA
2026-10-09 |
— | — | — | — | — | — | — |
7
|
|
DCS, EBITDA
[EUR m]
2026-10-09 |
— | — | — | — |
155.0
|
— | — | — |
|
DCS, EBITDA
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
150.3
|
— |
143.9
|
149.6
|
— |
|
DCS, EBITDA Margin (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
7
|
|
DCS, EBITDA Margin (in %)
(in %)
Consensus as of: 2026-10-09 |
— | — | — |
24.3
|
24.9
|
23.7
|
24.4
|
— |
|
DCS, Revenue
2026-10-09 |
— | — | — | — | — | — | — |
7
|
|
DCS, Revenue
[EUR m]
2026-10-09 |
— | — | — |
618.7
|
627.0
|
607.5
|
621.0
|
— |
|
DDS, EBITDA
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
7
|
|
DDS, EBITDA
EUR m
Consensus as of: 2026-10-09 |
— | — | — |
158.8
|
169.1
|
145.0
|
160.0
|
— |
|
DDS, EBITDA Margin (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
7
|
|
DDS, EBITDA Margin (in %)
in %
Consensus as of: 2026-10-09 |
— | — | — |
33.0
|
36.0
|
30.0
|
33.1
|
— |
|
DDS, Revenue
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
7
|
|
DDS, Revenue
EUR m
Consensus as of: 2026-10-09 |
— | — | — | — | — |
469.7
|
— | — |
|
DDS, Revenue
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
481.7
|
491.0
|
— |
483.0
|
— |
|
DPS
2026-10-09 |
— | — | — |
0.20
|
0.23
|
0.15
|
0.20
|
14
|
|
EBIT
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
EBIT
[EUR m]
2026-10-09 |
— | — | — |
215.2
|
231.0
|
196.0
|
214.7
|
— |
|
EBITDA
[EUR m]
2026-10-09 |
— | — | — |
309.5
|
— |
300.0
|
309.8
|
— |
|
EBITDA
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
EBITDA
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — | — |
319.0
|
— | — | — |
|
EBITDA Margin
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
EBITDA Margin
(in %)
2026-10-09 |
— | — | — |
28.1
|
28.6
|
27.1
|
28.1
|
— |
|
EPS
2026-10-09 |
— | — | — |
1.09
|
1.16
|
1.03
|
1.09
|
14
|
|
FCF
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
FCF
[EUR m]
2026-10-09 |
— | — | — |
79.3
|
101.0
|
54.0
|
78.0
|
— |
|
Net income
2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
Net income
[EUR m]
2026-10-09 |
— | — | — |
163.8
|
175.0
|
155.0
|
163.9
|
— |
|
Organic revenue growth (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
Organic revenue growth (in %)
(in %)
Consensus as of: 2026-10-09 |
— | — | — |
5.9
|
7.2
|
4.5
|
5.9
|
— |
|
Revenue
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
Revenue
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
1,103.2
|
1,143.5
|
1,076.6
|
1,101.0
|
— |
FY 2028 E
| Metric | Low | Average | High | Consensus (Mean) | Highest | Lowest | Median | Number of Estimates |
|---|---|---|---|---|---|---|---|---|
|
Capex
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
Capex
[EUR m]
2026-10-09 |
— | — | — |
-146.7
|
-120.0
|
-164.0
|
-151.0
|
— |
|
DCS, EBITDA
2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DCS, EBITDA
[EUR m]
2026-10-09 |
— | — | — | — |
173.0
|
— | — | — |
|
DCS, EBITDA
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
162.1
|
— |
154.0
|
161.1
|
— |
|
DCS, EBITDA Margin (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DCS, EBITDA Margin (in %)
(in %)
Consensus as of: 2026-10-09 |
— | — | — |
24.7
|
25.9
|
23.9
|
24.7
|
— |
|
DCS, Revenue
2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DCS, Revenue
[EUR m]
2026-10-09 |
— | — | — |
655.0
|
678.0
|
643.6
|
649.4
|
— |
|
DDS, EBITDA
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DDS, EBITDA
EUR m
Consensus as of: 2026-10-09 |
— | — | — |
175.9
|
182.5
|
155.0
|
178.3
|
— |
|
DDS, EBITDA Margin (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DDS, EBITDA Margin (in %)
in %
Consensus as of: 2026-10-09 |
— | — | — |
34.0
|
36.3
|
30.0
|
34.3
|
— |
|
DDS, Revenue
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
8
|
|
DDS, Revenue
EUR m
Consensus as of: 2026-10-09 |
— | — | — | — | — |
502.6
|
— | — |
|
DDS, Revenue
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
518.2
|
534.0
|
— |
516.5
|
— |
|
DPS
2026-10-09 |
— | — | — |
0.22
|
0.33
|
0.18
|
0.22
|
13
|
|
EBIT
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
EBIT
[EUR m]
2026-10-09 |
— | — | — |
237.9
|
260.0
|
218.0
|
237.0
|
— |
|
EBITDA
[EUR m]
2026-10-09 |
— | — | — |
339.8
|
— |
328.0
|
340.0
|
— |
|
EBITDA
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
EBITDA
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — | — |
350.0
|
— | — | — |
|
EBITDA Margin
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
EBITDA Margin
(in %)
2026-10-09 |
— | — | — |
28.9
|
29.4
|
27.7
|
29.0
|
— |
|
EPS
2026-10-09 |
— | — | — |
1.21
|
1.31
|
1.14
|
1.20
|
14
|
|
FCF
2026-10-09 |
— | — | — | — | — | — | — |
13
|
|
FCF
[EUR m]
2026-10-09 |
— | — | — |
113.3
|
159.0
|
66.6
|
111.4
|
— |
|
Net income
2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
Net income
[EUR m]
2026-10-09 |
— | — | — |
182.3
|
197.0
|
171.7
|
180.0
|
— |
|
Organic revenue growth (in %)
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
9
|
|
Organic revenue growth (in %)
(in %)
Consensus as of: 2026-10-09 |
— | — | — |
6.7
|
7.8
|
6.1
|
6.6
|
— |
|
Revenue
Consensus as of: 2026-10-09 |
— | — | — | — | — | — | — |
14
|
|
Revenue
[EUR m]
Consensus as of: 2026-10-09 |
— | — | — |
1,179.0
|
1,228.5
|
1,147.2
|
1,179.3
|
— |